BR9712168A - Processos de tratamento ou de prevenção de u distúrbio cardiovascular em um humano, de tratamento ou de prevenção de acidente vascular cerebral, trombose cerebral ou de perda de memória devido ao acidente vascular cerebral, de tratamento ou de prevenção de condições de fìgado gorduroso em um humano, de melhoria ou de manutenção da saúde cardiovascular, de tratamento ou de prevenção de diabetes em um humano e de redução dos nìveis de colesterol e de triglicerìdeo do soro, composição nutricional ou farmacêutica, medicamento, e, produto de fermentação delevedura vermelha adequado para liberação oral em humanos. - Google Patents

Processos de tratamento ou de prevenção de u distúrbio cardiovascular em um humano, de tratamento ou de prevenção de acidente vascular cerebral, trombose cerebral ou de perda de memória devido ao acidente vascular cerebral, de tratamento ou de prevenção de condições de fìgado gorduroso em um humano, de melhoria ou de manutenção da saúde cardiovascular, de tratamento ou de prevenção de diabetes em um humano e de redução dos nìveis de colesterol e de triglicerìdeo do soro, composição nutricional ou farmacêutica, medicamento, e, produto de fermentação delevedura vermelha adequado para liberação oral em humanos.

Info

Publication number
BR9712168A
BR9712168A BR9712168-1A BR9712168A BR9712168A BR 9712168 A BR9712168 A BR 9712168A BR 9712168 A BR9712168 A BR 9712168A BR 9712168 A BR9712168 A BR 9712168A
Authority
BR
Brazil
Prior art keywords
treatment
prevention
human
stroke
processes
Prior art date
Application number
BR9712168-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Mao L Zhang
Chi X Pong
Michael N Chang
Original Assignee
Pharmanex Inc
Univ Beijing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmanex Inc, Univ Beijing filed Critical Pharmanex Inc
Publication of BR9712168A publication Critical patent/BR9712168A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Botany (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
BR9712168-1A 1996-09-30 1997-09-29 Processos de tratamento ou de prevenção de u distúrbio cardiovascular em um humano, de tratamento ou de prevenção de acidente vascular cerebral, trombose cerebral ou de perda de memória devido ao acidente vascular cerebral, de tratamento ou de prevenção de condições de fìgado gorduroso em um humano, de melhoria ou de manutenção da saúde cardiovascular, de tratamento ou de prevenção de diabetes em um humano e de redução dos nìveis de colesterol e de triglicerìdeo do soro, composição nutricional ou farmacêutica, medicamento, e, produto de fermentação delevedura vermelha adequado para liberação oral em humanos. BR9712168A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72054896A 1996-09-30 1996-09-30
PCT/US1997/017574 WO1998014177A1 (fr) 1996-09-30 1997-09-29 Procede et compositions mettant en oeuvre des produits de fermentation a base de levure rouge

Publications (1)

Publication Number Publication Date
BR9712168A true BR9712168A (pt) 2000-01-18

Family

ID=24894390

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712168-1A BR9712168A (pt) 1996-09-30 1997-09-29 Processos de tratamento ou de prevenção de u distúrbio cardiovascular em um humano, de tratamento ou de prevenção de acidente vascular cerebral, trombose cerebral ou de perda de memória devido ao acidente vascular cerebral, de tratamento ou de prevenção de condições de fìgado gorduroso em um humano, de melhoria ou de manutenção da saúde cardiovascular, de tratamento ou de prevenção de diabetes em um humano e de redução dos nìveis de colesterol e de triglicerìdeo do soro, composição nutricional ou farmacêutica, medicamento, e, produto de fermentação delevedura vermelha adequado para liberação oral em humanos.

Country Status (9)

Country Link
EP (1) EP0932395A1 (fr)
JP (1) JP2001501621A (fr)
KR (1) KR20000048765A (fr)
AU (1) AU4658797A (fr)
BR (1) BR9712168A (fr)
CA (1) CA2267340A1 (fr)
HU (1) HUP9904650A2 (fr)
IL (1) IL129216A0 (fr)
WO (1) WO1998014177A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436406B1 (en) 2000-06-15 2002-08-20 A. Glenn Braswell Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
KR100426880B1 (ko) * 2002-02-04 2004-04-13 학교법인 영광학원 모나스쿠스 피로수스를 이용한 적색 메주색소의 제조방법
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
AU2004249060A1 (en) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. Composition for lowering serum uric acid level
US20100119600A1 (en) * 2007-06-01 2010-05-13 Joar Opheim Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
TW201038205A (en) * 2009-04-29 2010-11-01 Sunway Biotech Co Ltd The compositions of Monascus fermented products with a function that reduces body fatness formation and the method for manufacturing the same
JP2010273569A (ja) * 2009-05-26 2010-12-09 Wasaburo Sato メタボリックシンドローム改善作用を有する飲料及びサプリメント
JP5912361B2 (ja) * 2011-09-16 2016-04-27 晨暉生物科技股▲分▼有限公司 血液脂質を引き下げ、ｈｄｌコレステロールを引き上げることができる混合物とその製造方法
CN104024270B (zh) 2011-12-26 2016-07-06 北京北大维信生物科技有限公司 一种甾醇类衍生物、其制备方法及用途
CN113171316B (zh) * 2021-04-23 2022-06-14 科丝美诗(中国)化妆品有限公司 一种修复、缓解皮肤刺激化妆品及制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150037A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Hydronaphthalene compound
JP3168298B2 (ja) * 1993-02-05 2001-05-21 有限会社フジ・バイオ研究所 紅麹を使用した酒精飲料の製造法

Also Published As

Publication number Publication date
CA2267340A1 (fr) 1998-04-09
IL129216A0 (en) 2000-02-17
JP2001501621A (ja) 2001-02-06
KR20000048765A (ko) 2000-07-25
HUP9904650A2 (hu) 2000-05-28
AU4658797A (en) 1998-04-24
WO1998014177A1 (fr) 1998-04-09
EP0932395A1 (fr) 1999-08-04

Similar Documents

Publication Publication Date Title
EP1044009B8 (fr) Compositions contenant des produits fermentes a base de riz rouge et procedes associes
US5840715A (en) Dietary regimen of nutritional supplements for relief of symptoms of arthritis
EP1455600B1 (fr) Composition alimentaire et composition alimentaire pour animaux contenant un extrait végétal d'amelanchier favorisant la santé des os
US6136795A (en) Dietary regimen of nutritional supplements for relief of symptoms of arthritis
BR0214838A (pt) Composição para promoção de crescimento ósseo e manutenção da saúde óssea
EP1604677A1 (fr) Composition ayant des effets antioxidants, antinflammatoires et immunostimulants
BR9712168A (pt) Processos de tratamento ou de prevenção de u distúrbio cardiovascular em um humano, de tratamento ou de prevenção de acidente vascular cerebral, trombose cerebral ou de perda de memória devido ao acidente vascular cerebral, de tratamento ou de prevenção de condições de fìgado gorduroso em um humano, de melhoria ou de manutenção da saúde cardiovascular, de tratamento ou de prevenção de diabetes em um humano e de redução dos nìveis de colesterol e de triglicerìdeo do soro, composição nutricional ou farmacêutica, medicamento, e, produto de fermentação delevedura vermelha adequado para liberação oral em humanos.
NZ335086A (en) Bacillus thuringiensis pesticidal toxins and nucleotide sequences which encode these toxins
US20080031869A1 (en) Pain relief composition
Mali et al. Overview of nutraceuticals
CA2240165A1 (fr) Regime alimentaire a base de complements nutritionnels permettant de soulager les symptomes de l'arthrite
BRPI0410267A (pt) composições contendo enzimas, produtos alimentares dietéticos e medicamentos produzidos das mesmas e sua utilização para fins medicinais
WO2008100130A2 (fr) Composition contenant de l'extrait de piper sarmentosum (kadok) et du collagène
US20040086581A1 (en) Bio-energetic joint and arthritis pain formula
CN105942490A (zh) 一种防治高血脂高血糖高血压的复合酵素组合物
KR20170139780A (ko) 혈관 기능을 개선하는데 도움을 주는 서사향이 함유된 조성물
EP3381457B1 (fr) Composition physiologique active
CN109464651A (zh) 一种软骨代谢异常疾病改善用健康食品及药品组合物
Obaid The medical uses of Gum Acacia-Gum Arabic (GA) in human
CN1195529A (zh) 一种治疗跌打损伤的药物及其制备方法
WO2021124912A1 (fr) Composition pour promotion de la synthèse de sulfate de chondroïtine
CN112617206A (zh) 一种降低炎性细胞因子及调节免疫功能的复合益生菌及其应用
Suryawanshi et al. REVIEW ON: NUTRACEUTICALS AND ITS IMPACT ON HEALTHCARE
KR101866065B1 (ko) 식물성 식이유황 추출물 제조방법과 이를 함유하는 식초 음료 제조
Pizzorno Jr Natural medicine approach to treating osteoarthritis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A , 5A , 6A , 7A E 8A ANUIDADES.

B15K Others concerning applications: alteration of classification

Ipc: C12R 1/645 (2006.01), A23L 33/105 (2016.0